Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries?
Björnsson
Einar
E
Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. einar.bjornsson@medic.gu.se
Aabakken
Lars
L
Olafsson
Sigurdur
S
Bendtsen
Flemming
F
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004932:Esophageal and Gastric Varices / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D004945:Esophagoscopy; D006801:Humans; D008026:Ligation; D008103:Liver Cirrhosis / Q000150:complications / Q000453:epidemiology; D018579:Patient Selection; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D017410:Practice Guidelines as Topic; D012537:Scandinavian and Nordic Countries / Q000453:epidemiology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D014662:Vasoconstrictor Agents